Medtronic plc
MDT
NYSE·Healthcare·Medical - Devices·Mkt cap $120.5B
$94.17
▲ +1.15%
P/E
23.02
Mkt Cap
$120.5B
52-Wk Range
$73.31–$106.33
52-Week Range
$73.31 - $106.33
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 1.3% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Comprehensive medical device portfolio
- Global market presence
- Advanced technological innovation
- Strong research and development capabilities
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Aging global population
Value
Attractively priced below Medical Devices peer average
Momentum
Strong
+16.7% over 3m
Quality
Excellent
Excellent business quality
Dividend
Solid
3.03% yield
Smart-money signal
Who's buying MDT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 17, 2026
SEP 1, 2026
Reported EPS of $1.45 vs $1.39 consensus (+4.3% surprise). Revenue of $9.8B vs $9.5B expected (+2.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.3%
Revenue trend · last 8Q
—
+3%
—
+8%
+7%
+9%
+10%
+14%
Q2 24
Q3 25
Q4 25
Q1 25
Q2 25
Q3 26
Q4 26
Q1 27
$8.4B
$8.3B
$8.9B
$8.6B
$9.0B
$9.0B
$9.8B
$9.8B
Margins · last 8Q
Gross
65.0%
Operating
18.1%
Profit
15.1%
Wall Street consensus
17 analysts · 71% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
71%
Hold
29%
Sell
0%
Median Price Target
$100.00
▲ +6.2% vs $94.17
Latest: UBS · Sep 3, 2026
1 analyst covering
vs Industry
How MDT stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related